In the past decades, the production of biopharmaceuticals has gained high interest due to its great sensitivity, specificity, and lower risk of negative effects to patients. Biopharmaceuticals …
Metabolic differences between normal and cancerous cells have been used as a point of view for developing anticancer drugs. Some degrading enzymes of certain amino acids …
PG Patel, HZ Panseriya, AK Vala, BP Dave… - Process …, 2022 - Elsevier
L-asparaginase, an amidohydrolase that catalyses break down of L-asparagine into aspartic acid and ammonia, is one of the most prominent biopharmaceuticals. L-asparaginase (LA) …
N Kango, UK Jana, R Choukade - … : Basic and Applied Aspects of Fungi, 2019 - Springer
Fungi, being obligate heterotrophs, are natural decomposers and elaborate a number of enzymes. Currently, more than half of the industrial enzymes are of fungal origin and are …
H Chi, M Chen, L Jiao, Z Lu, X Bie, H Zhao, F Lu - Foods, 2021 - mdpi.com
L-asparaginase (EC 3.5. 1.1) is a well-known agent that prevents the formation of acrylamide both in the food industry and against childhood acute lymphoblastic leukemia in …
H Saeed, A Hemida, N El-Nikhely… - International journal of …, 2020 - Elsevier
Abstract L-Asparaginase (L-ASNase EC 3.5. 1.1) is considered as an important biopharmaceutical drug enzyme in the treatment of childhood acute lymphoblastic leukemia …
Recombinant enzyme expression in Escherichia coli is one of the most popular methods to produce bulk concentrations of protein product. However, this method is often limited by the …
Introduction: The bacterial enzyme has gained more attention in therapeutic application because of the higher substrate specificity and longer half-life. L-asparaginase is an …
The enzyme L-asparaginase (L-ASNase) is used in the treatment of Acute Lymphoblastic Leukemia. The preparations of this enzyme for clinical use are derived from bacterial …